Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Karolinska Institute's Aprea Therapeutics has priced its shares at $15 to raise $85m, with stock rising a third to $20.50 on the first day of trading.

Notion Capital Venture Capital IV has added Texas A&M University to its limited partners as it seeks a $150m final close.

Livzon Pharmaceutical Group has been identified as an investor by MIT spinout Elicio Therapeutics, which just completed a series B round that takes its total financing to $63m.

GV has contributed to a $92m series B for Tenaya, three years after it was spun out of Gladstone Institutes and University of Texas Southwestern Medical Center.

Icosavax has launched out of University of Washington with $51m in series A funding to move a vaccine for respiratory syncytial virus into a phase 1b trial.

Frequency, a regenerative medicine developer based on MIT and Harvard research, priced shares at the bottom of its range to raise $84m in its IPO.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CSU Ventures boosted its licensing income by more than two-fold and established six new spinouts during the 2018-19 academic year.

Infineon Technologies Austria has bought its portfolio company Dice, a Johannes Kepler University spinout that produces integrated circuits for radar-powered sensors.